These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 2143351
21. Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs. Kleinert HD, Volpe M, Odell G, Marion D, Atlas SA, Camargo MJ, Laragh JH, Maack T. Hypertension; 1986 Apr; 8(4):312-6. PubMed ID: 2937724 [Abstract] [Full Text] [Related]
22. Hemodynamic effects of alpha-human atrial natriuretic peptide in healthy volunteers. Hynynen M, Kupari M, Salmenperä M, Tikkanen I, Heinonen J, Fyhrquist F, Tötterman KJ. J Cardiovasc Pharmacol; 1988 Jun; 11(6):711-5. PubMed ID: 2457767 [Abstract] [Full Text] [Related]
23. Effects of atrial natriuretic peptide on coronary vascular resistance in the intact awake dog. Laxson DD, Dai XZ, Schwartz JS, Bache RJ. J Am Coll Cardiol; 1988 Mar; 11(3):624-9. PubMed ID: 2963852 [Abstract] [Full Text] [Related]
24. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Friedrich SP, Lorell BH, Rousseau MF, Hayashida W, Hess OM, Douglas PS, Gordon S, Keighley CS, Benedict C, Krayenbuehl HP. Circulation; 1994 Dec; 90(6):2761-71. PubMed ID: 7994819 [Abstract] [Full Text] [Related]
25. Effects of atrial natriuretic peptide on the coronary arterial vasculature in humans. Chu A, Morris KG, Kuehl WD, Cusma J, Navetta F, Cobb FR. Circulation; 1989 Dec; 80(6):1627-35. PubMed ID: 2557173 [Abstract] [Full Text] [Related]
26. Acute effects of atrial natriuretic peptide on left ventricular diastolic function. a pulsed wave Doppler study in man. Clarkson PB, Wheeldon NM, Macleod C, Coutie W, MacDonald TM. Eur Heart J; 1995 Nov; 16(11):1710-15. PubMed ID: 8881869 [Abstract] [Full Text] [Related]
27. Effects of therapeutic doses of human atrial natriuretic peptide on load and myocardial performance in patients with congestive heart failure. Mizuno O, Onishi K, Dohi K, Motoyasu M, Okinaka T, Ito M, Isaka N, Nakano T. Am J Cardiol; 2001 Oct 15; 88(8):863-6. PubMed ID: 11676948 [Abstract] [Full Text] [Related]
28. Captopril restores hemodynamic responsiveness to atrial natriuretic peptide in rats with heart failure. Raya TE, Lee RW, Westhoff T, Goldman S. Circulation; 1989 Dec 15; 80(6):1886-92. PubMed ID: 2532077 [Abstract] [Full Text] [Related]
29. Hemodynamic effects of synthetic atrial natriuretic factor (ANF) in dogs with acute left ventricular failure. Sweet CS, Ludden CT, Frederick CM, Ribeiro LG, Nussberger J, Slater EE, Blaine EH. Eur J Pharmacol; 1985 Sep 24; 115(2-3):267-76. PubMed ID: 2933267 [Abstract] [Full Text] [Related]
30. Effect of atrial natriuretic factor on transmural myocardial blood flow distribution in the dog. Bauman RP, Rembert JC, Himmelstein SI, Klotman PE, Greenfield JC. Circulation; 1987 Sep 24; 76(3):705-9. PubMed ID: 2957114 [Abstract] [Full Text] [Related]
31. Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart. Yamamoto K, Burnett JC, Redfield MM. Am J Physiol; 1997 Nov 24; 273(5):H2406-14. PubMed ID: 9374778 [Abstract] [Full Text] [Related]
32. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure. Haug C, Metzele A, Kochs M, Hombach V, Grünert A. Clin Cardiol; 1993 Jul 24; 16(7):553-7. PubMed ID: 8348764 [Abstract] [Full Text] [Related]
33. Effects of low-dose flosequinan on left ventricular systolic and diastolic chamber performance. Starling MR. Am Heart J; 1994 Jul 24; 128(1):124-33. PubMed ID: 8017265 [Abstract] [Full Text] [Related]
34. [Changes in PTCA. A model of ischemia in humans]. Prachar H. Acta Med Austriaca Suppl; 1991 Jul 24; 42():1-35. PubMed ID: 1830715 [Abstract] [Full Text] [Related]
35. Cardiovascular effects of intravenous and intracoronary administration of atrial natriuretic peptide in halothane anesthetized dogs. Iwanaga R, Hori S, Suzuki H, Nakajima S, Saruta T, Kojima S, Fukuda K, Satoh T, Kusuhara M, Handa S. Life Sci; 1988 Jul 24; 42(13):1279-86. PubMed ID: 2965292 [Abstract] [Full Text] [Related]
36. Plasma atrial natriuretic factor in essential hypertension: relation to cardiac size, function and systemic hemodynamics. Ganau A, Devereux RB, Atlas SA, Pecker M, Roman MJ, Vargiu P, Cody RJ, Laragh JH. J Am Coll Cardiol; 1989 Sep 24; 14(3):715-24; discussion 725-7. PubMed ID: 2527901 [Abstract] [Full Text] [Related]
37. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS. J Clin Invest; 1985 Feb 24; 75(2):643-9. PubMed ID: 3973022 [Abstract] [Full Text] [Related]
38. Pathophysiologic levels of atrial natriuretic factor do not alter reflex sympathetic control: direct evidence from microneurographic studies in humans. Roach PJ, Sanders JS, Berg WJ, Mark AL, Ebert TJ, Ferguson DW. J Am Coll Cardiol; 1990 May 24; 15(6):1318-30. PubMed ID: 2139443 [Abstract] [Full Text] [Related]
39. Intracoronary albunex. Its effects on left ventricular hemodynamics, function, and coronary sinus flow in humans. Ten Cate FJ, Widimsky P, Cornel JH, Waldstein DJ, Serruys PW, Waaler A. Circulation; 1993 Nov 24; 88(5 Pt 1):2123-7. PubMed ID: 8222106 [Abstract] [Full Text] [Related]
40. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern. Yu CM, Sanderson JE, Shum IO, Chan S, Yeung LY, Hung YT, Cockram CS, Woo KS. Eur Heart J; 1996 Nov 24; 17(11):1694-702. PubMed ID: 8922918 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]